Based on the relationship among melanoma, PD-1 inhibitors and mitochondria, this review discusses the recent research progress on the role of mitochondria in the treatment of melanoma resistance to PD-1 inhibitors to explore strategies for improving the survival rate of patients through the combination of mitochondrial activation and PD-1 inhibition. This evidence concerns the gene PDCD1 and melanoma.